|
Index of reports
> Life Threatening Events (89)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erbitux (Cetuximab) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 89 Next >>
Possible Erbitux side effects in male
Reported by a physician from France on 2012-08-16
Patient: male
Reactions: Anaphylactic Shock, Headache, Hyperhidrosis, Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: 816mg single dose
Indication: Tonsil Cancer
Start date: 2012-07-24
End date: 2012-07-24
Zofran
Dosage: 8mg single dose
Indication: Nausea
Start date: 2012-07-24
End date: 2012-07-24
Other drugs received by patient: Solu-Medrol; Polaramine
Possible Erbitux side effects in male
Reported by a pharmacist from United States on 2012-08-10
Patient: male
Reactions: Chest Discomfort, Nausea, Chills, Erythema, Chest Pain, Feeling Hot, Dizziness, Infusion Related Reaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Erbitux
Possible Erbitux side effects in 76 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-10
Patient: 76 year old male
Reactions: Confusional State, Transient Ischaemic Attack, Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Irinotecan HCL
Possible Erbitux side effects in 51 year old female
Reported by a physician from Germany on 2012-07-30
Patient: 51 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Endocarditis, Device Related Infection, Cardiac Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Possible Erbitux side effects in 66 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-27
Patient: 66 year old male, weighing 64.0 kg (140.8 pounds)
Reactions: Mucosal Inflammation, Pneumonia Aspiration, Dysphagia, Pain, Toxic Epidermal Necrolysis, General Physical Health Deterioration, Rash Maculo-Papular, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Perenterol; Novasource; Remeron; Aldactone; Concor; Levothyroxine Sodium; Nexium; Dipiperon; Fragmin; Cordarone; Zestril
Possible Erbitux side effects in 63 year old male
Reported by a physician from Germany on 2012-07-27
Patient: 63 year old male
Reactions: Electrocardiogram Abnormal, Acute Myocardial Infarction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-06-19
Fluorouracil
Indication: Colon Cancer
Start date: 2012-06-19
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-06-19
Erbitux
Indication: Colon Cancer
Start date: 2012-06-19
Other drugs received by patient: Quinine Sulfate; Omeprazole; Zopiclone; Lyrica; Mobic
Possible Erbitux side effects in 62 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-25
Patient: 62 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Neutropenia, Idiopathic Thrombocytopenic Purpura, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-01-31
End date: 2012-01-31
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-02-07
End date: 2012-02-07
Irinotecan Hydrochloride
Dosage: 200 mg, 1x/day
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-01-17
Erbitux
Dosage: 600 mg, 1x/day
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-01-17
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-02-14
End date: 2012-02-14
Irinotecan Hydrochloride
Dosage: 200 mg, 1x/day
Start date: 2012-02-14
End date: 2012-02-14
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-01-24
End date: 2012-01-24
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-02-21
End date: 2012-02-21
Irinotecan Hydrochloride
Dosage: 200 mg, 1x/day
Start date: 2012-01-31
End date: 2012-01-31
Other drugs received by patient: Globulin N; Platelets, Human Blood; Decadron; Prednisolone; Famotidine; Promacta; Esomeprazole Magnesium; Amoxicillin; Clarithromycin
Possible Erbitux side effects in 62 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-23
Patient: 62 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Neutropenia, Idiopathic Thrombocytopenic Purpura, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-01-24
End date: 2012-01-24
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-02-21
End date: 2012-02-21
Erbitux
Dosage: 600 mg, 1x/day
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-01-17
Irinotecan Hydrochloride
Dosage: 200 mg, 1x/day
Start date: 2012-02-14
End date: 2012-02-14
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-02-07
End date: 2012-02-07
Irinotecan Hydrochloride
Dosage: 200 mg, 1x/day
Start date: 2012-01-31
End date: 2012-01-31
Irinotecan Hydrochloride
Dosage: 200 mg, 1x/day
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-01-17
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-01-31
End date: 2012-01-31
Erbitux
Dosage: 400 mg, 1x/day
Start date: 2012-02-14
End date: 2012-02-14
Other drugs received by patient: Famotidine; Globulin N; Esomeprazole Magnesium; Platelets, Human Blood; Decadron; Clarithromycin; Amoxicillin; Promacta; Prednisolone
Possible Erbitux side effects in 62 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-16
Patient: 62 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: 600mg,17-17jan12;250mg 1feb12-21feb12
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-02-21
Irinotecan HCL
Dosage: on 14feb2012 taken with erbiux
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-02-14
Other drugs received by patient: Decadron; Famotidine
Possible Erbitux side effects in 60 year old female
Reported by a physician from United Kingdom on 2012-07-12
Patient: 60 year old female, weighing 61.0 kg (134.2 pounds)
Reactions: Dermatitis Acneiform, Intestinal Ischaemia, Intestinal Perforation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: route: also iv drip
Indication: Colorectal Cancer Metastatic
Start date: 2005-11-16
End date: 2006-03-16
Irinotecan HCL
Dosage: route: also iv drip
Indication: Colorectal Cancer Metastatic
Start date: 2005-11-16
End date: 2006-03-16
Possible Erbitux side effects in 60 year old female
Reported by a physician from Germany on 2012-07-03
Patient: 60 year old female
Reactions: Dermatitis Acneiform, Intestinal Perforation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Erbitux
Indication: Colorectal Cancer Metastatic
Start date: 2005-11-16
End date: 2006-03-16
Irinotecan HCL
Indication: Colorectal Cancer Metastatic
Start date: 2005-11-16
End date: 2006-03-16
Possible Erbitux side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03
Patient: 60 year old female
Reactions: Intestinal Ischaemia, Dermatitis Acneiform, Intestinal Perforation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Indication: Colorectal Cancer Metastatic
Start date: 2005-11-16
End date: 2006-03-16
Irinotecan HCL
Indication: Colorectal Cancer Metastatic
Start date: 2005-11-16
End date: 2006-03-16
Possible Erbitux side effects in 69 year old male
Reported by a physician from Japan on 2012-06-27
Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Erbitux
Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-03-05
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Possible Erbitux side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Coma, Microcytic Anaemia, Anaemia Macrocytic, Multi-Organ Failure, Coombs Positive Haemolytic Anaemia, Aplasia Pure RED Cell, Thrombocytopenia, Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Levoleucovorin Calcium
Dosage: 300 mg/m2 for 4 days,every 15 days
Start date: 2008-03-20
End date: 2008-10-09
Levoleucovorin Calcium
Dosage: 400 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-05-05
End date: 2007-08-01
Fluorouracil
Dosage: 1000 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-05-05
End date: 2007-08-01
Irinotecan HCL
Dosage: unspecified dose for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2008-09-04
End date: 2008-10-09
Eloxatin
Dosage: 25 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-05-05
End date: 2007-08-01
Fluorouracil
Dosage: 1000 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Eloxatin
Dosage: 25 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Fluorouracil
Dosage: 800 mg/m2 for 4 days,every 15 days
Start date: 2008-03-20
End date: 2008-10-09
Emend
Dosage: unspecified dose for 4 days,every 15 days
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2008-09-04
End date: 2008-10-09
Levoleucovorin Calcium
Dosage: 400 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Eloxatin
Dosage: 20 mg/m2; frequency unspecified
Start date: 2008-03-20
End date: 2008-10-09
Erbitux
Dosage: 500 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-08-01
End date: 2007-01-01
Erbitux
Dosage: 500 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Erbitux
Dosage: 500 mg/m2 for 4 days,every 15 days
Start date: 2008-03-20
End date: 2008-10-09
Possible Erbitux side effects in 69 year old male
Reported by a consumer/non-health professional from Japan on 2012-06-08
Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Erbitux
Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-03-05
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Fluorouracil
Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Possible Erbitux side effects in 67 year old male
Reported by a consumer/non-health professional from United States on 2012-06-06
Patient: 67 year old male
Reactions: Aphasia, Fall, Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Possible Erbitux side effects in 60 year old male
Reported by a consumer/non-health professional from United States on 2012-06-01
Patient: 60 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Haemorrhage, Rash Pruritic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Possible Erbitux side effects in 34 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29
Patient: 34 year old male, weighing 72.0 kg (158.4 pounds)
Reactions: Coma, Microcytic Anaemia, Anaemia Macrocytic, Multi-Organ Failure, Coombs Positive Haemolytic Anaemia, Aplasia Pure RED Cell, Thrombocytopenia, Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Levoleucovorin Calcium
Dosage: 400 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Fluorouracil
Dosage: 800 mg/m2 for 4 days,every 15 days
Start date: 2008-03-20
End date: 2008-10-09
Eloxatin
Dosage: 25 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Erbitux
Dosage: 500 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-08-01
End date: 2007-01-01
Erbitux
Dosage: 500 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Levoleucovorin Calcium
Dosage: 300 mg/m2 for 4 days,every 15 days
Start date: 2008-03-20
End date: 2008-10-09
Fluorouracil
Dosage: 1000 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-05-05
End date: 2007-08-01
Irinotecan HCL
Dosage: unspecified dose for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2008-09-04
End date: 2008-10-09
Eloxatin
Dosage: 25 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-05-05
End date: 2007-08-01
Erbitux
Dosage: 500 mg/m2 for 4 days,every 15 days
Start date: 2008-03-20
End date: 2008-10-09
Emend
Dosage: unspecified dose for 4 days,every 15 days
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2008-09-04
End date: 2008-10-09
Levoleucovorin Calcium
Dosage: 400 mg/m2 for 4 days,every 15 days
Indication: Colorectal Cancer Metastatic
Start date: 2007-05-05
End date: 2007-08-01
Fluorouracil
Dosage: 1000 mg/m2 for 4 days,every 15 days
Start date: 2008-01-21
End date: 2008-01-01
Eloxatin
Dosage: 20 mg/m2; frequency unspecified
Start date: 2008-03-20
End date: 2008-10-09
Possible Erbitux side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22
Patient: male, weighing 66.2 kg (145.7 pounds)
Reactions: Dyspnoea, Unresponsive To Stimuli, Snoring, Pulse Absent
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Erbitux
Dosage: 700mg iv
Indication: Head and Neck Cancer
Erbitux
Possible Erbitux side effects in 55 year old female
Reported by a consumer/non-health professional from Germany on 2012-04-26
Patient: 55 year old female
Reactions: Gastric Ulcer Haemorrhage, Anaemia, Melaena
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1 df: 1 injection
Indication: Tonsil Cancer
Start date: 2012-02-09
End date: 2012-02-09
Zantac
Dosage: injection
Indication: Premedication
Start date: 2012-02-16
End date: 2012-02-16
Zofran
Dosage: 1 df: 1 injection
Start date: 2012-02-09
End date: 2012-02-09
Dexamethasone Sodium Phosphate
Dosage: injection
Indication: Tonsil Cancer
Start date: 2012-02-16
End date: 2012-02-16
Polaramine
Dosage: injection
Indication: Premedication
Start date: 2012-02-16
End date: 2012-02-16
Erbitux
Dosage: injection
Indication: Tonsil Cancer
Start date: 2012-02-16
End date: 2012-02-16
Other drugs received by patient: Acetaminophen
Possible Erbitux side effects in 73 year old male
Reported by a consumer/non-health professional from Germany on 2012-04-26
Patient: 73 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Stomatitis, Neuropathy Peripheral, Interstitial Lung Disease, Skin Disorder
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: also 380mg from 10mar-1sep11.
Indication: Rectosigmoid Cancer
Start date: 2011-03-10
End date: 2011-09-01
Oxaliplatin
Dosage: also iv drip 100 , 10mar-1sep11.
Indication: Rectosigmoid Cancer
Start date: 2011-03-10
End date: 2011-09-01
Other drugs received by patient: Isovorin; Leucovorin Calcium; Fluorouracil
Possible Erbitux side effects in female
Reported by a physician from France on 2012-04-24
Patient: female
Reactions: Gastric Ulcer Haemorrhage, Anaemia, Melaena
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Dosage: 20mg cyclic
Indication: Premedication
Start date: 2012-02-16
End date: 2012-02-16
Zofran
Dosage: 8mg cyclic
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-09
End date: 2012-02-09
Polaramine
Dosage: 5mg cyclic
Indication: Premedication
Start date: 2012-02-16
End date: 2012-02-16
Erbitux
Dosage: 250mgm2 cyclic
Indication: Tonsil Cancer
Start date: 2012-02-16
End date: 2012-02-16
Zantac
Dosage: 50mg cyclic
Indication: Premedication
Start date: 2012-02-16
End date: 2012-02-16
Carboplatin
Indication: Tonsil Cancer
Start date: 2012-02-09
End date: 2012-02-09
Other drugs received by patient: Acetaminophen
Possible Erbitux side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-23
Patient: 73 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Fatigue, Dyspnoea, Embolism, Abdominal Pain Upper, Cough
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Taxol
Dosage: paclitaxel 200mg/m2 days 71 and 92
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-05
End date: 2010-04-05
Erbitux
Dosage: cetuximab 250 mg/m2 days 50,57,64,71,78, 85,92,99,106
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-12
End date: 2010-04-12
Carboplatin
Dosage: carboplatin auc=6 days 71 and 92
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-05
End date: 2010-04-05
Possible Erbitux side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-23
Patient: 59 year old male
Reactions: Diverticular Perforation, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: 80 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-11-30
Cisplatin
Dosage: 80 mg/m2 unk iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
Erbitux
Dosage: 400 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-11-30
Vinorelbin INN (Vinorelbine Tartrate) Solution FOR Injection. Mfr: NOT
Dosage: 25 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-12-05
Other drugs received by patient: Magnesium; Ativan; Prochlorperazine; Glaxal Base; Uremol
Possible Erbitux side effects in male
Reported by a physician from Japan on 2012-04-20
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Jaundice, Bile Duct Stenosis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Irinotecan Hydrochloride
Dosage: dosage is uncertain.
Indication: Rectal Cancer Recurrent
Xeloda
Administration route: Oral
Indication: Rectal Cancer Recurrent
Start date: 2009-12-15
End date: 2010-10-13
Oxaliplatin
Dosage: dosage is uncertain.
Indication: Rectal Cancer Recurrent
Start date: 2009-12-15
Erbitux
Dosage: dosage is uncertain.
Indication: Rectal Cancer Recurrent
Other drugs received by patient: Novorapid; Lantus; Pydoxal
Possible Erbitux side effects in 49 year old male
Reported by a consumer/non-health professional from United States on 2012-04-17
Patient: 49 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Syncope, Pneumonia Aspiration, Asterixis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: 1st dose 400mg/m2 then wk 250mg/m2 on day 1 cycle 1. on 2mar11:1day-ong-unk recent inf:20apr2011
Indication: Head and Neck Cancer
Start date: 2011-03-02
Alimta
Dosage: last dose on 13apr11.
Indication: Head and Neck Cancer
Start date: 2011-03-02
Cisplatin
Dosage: recent inf:13apr2011
Indication: Head and Neck Cancer
Start date: 2011-03-02
Other drugs received by patient: Lamotrgine; Lyrica; Fentanyl; Folic Acid; Lactulose; Vitamin B-12; Pantoprazole; Morphine; Dexamethasone
Possible Erbitux side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-09
Patient: 59 year old male
Reactions: Diverticular Perforation, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: 400 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-11-30
Cisplatin
Dosage: 80 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
Vinorelbine
Dosage: 25 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-12-05
Erbitux
Dosage: 80 mg/m2 iv
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-11-30
Other drugs received by patient: Prochlorperazine; Glaxal Base; Ativan; Uremol; Magnesium
Possible Erbitux side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-09
Patient: 59 year old male
Reactions: Diverticular Perforation, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: interrupted on 30nov11 last dose:30nov11 4 courses
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-12-05
Erbitux
Dosage: 14sep-14sep11,400mg/m2 05oct-30nov11,250mg/m2 last dose:30nov11 delay 5-19dec11 restart19dec11
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
Cisplatin
Dosage: interrupted on 30nov11 last dose:30nov11 4 courses 80mg
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-12-05
Other drugs received by patient: Uremol; Magnesium; Uremol; Prochlorperazine; Ativan; Glaxal Base
Possible Erbitux side effects in 62 year old male
Reported by a consumer/non-health professional from Germany on 2012-03-30
Patient: 62 year old male, weighing 51.0 kg (112.2 pounds)
Reactions: Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Erbitux
Dosage: 600mg,17-17jan12;400mg -21feb12
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-02-21
Irinotecan HCL
Dosage: on 14feb2012 taken with erbiux
Indication: Colon Cancer
Start date: 2012-01-17
End date: 2012-02-14
Other drugs received by patient: Decadron; Famotidine
Possible Erbitux side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-26
Patient: 59 year old male
Reactions: Diverticular Perforation, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: interrupted on 30nov11 last dose:30nov11 4 courses 80mg
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-12-05
Erbitux
Dosage: 14sep-14sep11,400mg/m2 05oct-30nov11,250mg/m2 last dose:30nov11 delay 5-19dec11 restart19dec11
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
Vinorelbine
Dosage: interrupted on 30nov11 last dose:30nov11 4 courses
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-14
End date: 2011-12-05
Other drugs received by patient: Glaxal Base; Ativan; Magnesium; Uremol; Uremol; Prochlorperazine
Page 1 Next >>
|